Labcorp Perspectives: Oncology
Labcorp Perspectives: Oncology
Podcast Description
Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:
• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment
• Practical applications: Learning how precision medicine translates from lab to the clinic
• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutions
More than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.
Podcast Insights
Content Themes
The series covers a range of topics including groundbreaking research in cancer treatment, practical applications of precision medicine, and the real-world challenges in oncology care. For example, episodes feature discussions on tumor-agnostic therapies, the significance of genetic testing in prostate cancer care, and the clinical relevance of biomarkers, with a particular emphasis on how these advancements can directly improve patient outcomes.
Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:
• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment
• Practical applications: Learning how precision medicine translates from lab to the clinic
• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutions
More than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.
What does nuclear grading really reveal in the modern molecular era of endometrial cancer care?
In this episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs, Senior Director of Medical Affairs, sits down with gynecologic pathologist Dr. Tricia Newman and anatomic and molecular pathologist Dr. Kyle Strickland to unpack the surprising findings from their USCAP-presented study.
Step into the pathologist’s perspective as the team breaks down how tumor grading is performed, why nuclear atypia matters, and the sometimes-conflicting role of molecular testing like MSI and TP53. Discover why grading variability among experts can shift treatment plans—and how more standardized criteria and emerging AI tools could transform future diagnostics.
Whether you’re a practicing pathologist, oncologist, or keen to understand the future of cancer diagnostics, this episode delivers insights on integrating traditional morphology with next-generation molecular profiling. Find out what’s next for endometrial cancer grading and how these innovations might impact clinical decisions worldwide.
Tune in now to hear what’s on the horizon for cancer grading and patient care.
Follow Us
- LinkedIn @labcorp
- X @labcorp
- Facebook @labcorp
- Instagram @labcorp
- YouTube @LabCorpMedia
Presented by Labcorp Oncology
www.oncology.labcorp.com
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.